-
-
[1] Batall R, B renner DA.L iver F ibrosis[J].J C lin Investig, 2005, 115 (2) ∶209-219. [2] Rockey DC.Antifibrotic therapy in chron ic liver d isease[J].C linGaetroenterolHepatol, 2005, 32∶95-107. [3] G resner AM.Pathogenesis of liver fibrosis.B iom ed ical progress[J].2003, 16∶41-46. [4] Bataller R, North KE, B renner DA.Genetic polymorph ism s and theprogression of liver fibrosis:Acritical appraisal[J].Hepatology, 2003, 37 (3) ∶493-503. [5] Canbay A, Friedman SL, GoresG J.Apoptosis:the nexus of liver in-jury and fibrosis[J].Hepatology, 2004, 38 (2) ∶273-278. [6] L im in C, Andrew G, Jin S, et al.A ltered expression of gene in-volved in hepatic morphogenesis and fibrogenesis are identified bycDNA m icroarray analysis in b iliary atresia[J].Hepatology, 2003, 38∶567-576. [7] Scheuer P.L iver b iopsy size mattes in chron ic hepatitis:b igger isbetter[J].Hepatology, 2003, 38 (6) ∶1356-1359. [8] Bedossa P, Dargere D, Parad is.Sampling variab ility of liver fibrosisin chron ic hepatitis C[J].Hepatology, 2003, 38 (6) ∶1449-1457. [9] Poynard T, M cHutch ison J, MannasM, et al.B iochem ical surrogatemarkers of liver fibrosis and activity in a random ized trial of peginter-feron alfa-2b and ribavirin[J].Hepatology, 2003, 38∶481-492. [10] Rose E, Adam s L, Prins A, et al.Validation of the F ibro Test b io-chem icalmarkers score in assessing liver fibrosis in hepatitis C pa-tients[J].C lim chem, 2003, 49 (3) ∶450-454. [11] G iann in i E, Testa R.Non invasive d iagnosis of fibrosis:the truth israrely pure and never simple[J].Hepatology, 2003, 38 (5) ∶1312-1313. [12] Zhang BB, CaiWM, W engHL, et al.D iagnostic value of PDGF-BB, TGF-131, MMP-1 and TIMP-1 in serum and PBMCs forhepatic fibrosis[J].W orld J Gastroenteral, 2003, 9 (11) ∶2490-2496. [13] Adam s PC, ArtharM J, Boyer TD, et al.Screen ing in liver d isea-ses:Report of an AASLD C lin iscalworkshop[J].Hepatology, 2004, 39 (5) ∶1204-1212. [14]陈煜, 王宝恩, 贾继东, 等.慢性乙型肝炎肝纤维化程度的无创伤性评估[J].中华肝脏病杂志, 2003, 11 (6) ∶354-357. [15] Yuk iko S, Katsuya S, Tomoyuk i K, et al.Noinvasive pred iction offibrosis by a novel serum marker in patients w ith chron ic hepatitis C[J].Hepatology, 2003, 38 (4) ∶suppl:438A. [16]翁红雷, 蔡卫民, 王宝恩, 等.重组干扰素γ治疗慢性乙型肝炎纤维化临床研究[J].中华医学杂志, 2003, 83 (11) ∶943-947.
本文二维码
计量
- 文章访问数: 1842
- HTML全文浏览量: 2
- PDF下载量: 707
- 被引次数: 0